Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Remedy Robotics is a surgical robotics company that has developed the world's first remotely operable endovascular robot, primarily targeting stroke treatment to make endovascular care accessible…

Remedy Robotics is a surgical robotics company that has developed the world's first remotely operable endovascular robot, primarily targeting stroke treatment to make endovascular care accessible…
Product: Remedy N1 System — remotely operated endovascular robot with AI-assisted navigation
Clinical milestones: Remote in-vivo trials (2022) and first-in-human procedures (Nov–Dec 2024)
Founders: David Bell and Jake Sganga
Funding: Reported total raised ~$38M; investors include DCVC, Blackbird, KdT Ventures
Endovascular intervention for neurovascular and cardiovascular conditions, with emphasis on stroke treatment and widening geographic access to care.
2021
DeepTech
Seed funding announced May 2021 with participation from KdT Ventures, Pathbreaker Ventures, and Future Shape
Series A announced May 2022 with participation from existing investors including DCVC, KdT Ventures, Pathbreaker Ventures, and Future Shape
“Investors include DCVC, Blackbird, KdT Ventures, Pathbreaker Ventures, and Future Shape”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
400+
New This Week